$125 | Single User
$250 | Site License
$375 | Global License

Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review
[Lowest Price Guaranteed: $125]

Published by Global Data: 28 Mar 2019 | 231982 | In Stock
Related Topics: Business , Financial , Healthcare , Huntington's Disease

Introduction

Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Active Biotech AB (Active Biotech) is a biotechnology company that develops and commercializes pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company’s key products in development include Laquinimod (neurodegenerative diseases), Anyara (cancer), Tasquinimod (cancer), Paquinimod (Systemic Sclerosis), and SILC (autoimmune diseases). It has licensing agreements with Teva Pharmaceutical Industries, NeoTX, Ipsen, Teva Neuroscience and MediGene AG. Active Biotech is headquartered in Lund, Sweden.

Active Biotech AB Key Recent Developments

Feb 14,2019 Active Biotech year-end report January - December 2018

Nov 14,2018 Active Biotech - Interim report January - September 2018

Sep 13,2018 TOPC : Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018" [Newswire : Healthcare - GNW RSS]

Sep 07,2018 Teva returns laquinimod global rights to Active Biotech

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review

  • Table of Contents

    Table of Contents

    List of Tables

    List of Figures

    Section 1 - About the Company

    Active Biotech AB - Key Facts

    Active Biotech AB - Key Employees

    Active Biotech AB - Key Employee Biographies

    Active Biotech AB - Major Products and Services

    Active Biotech AB - History

    Active Biotech AB - Company Statement

    Active Biotech AB - Locations And Subsidiaries

    Head Office

    Other Locations & Subsidiaries

    Section 2 – Company Analysis

    Company Overview

    Active Biotech AB - Business Description

    Active Biotech AB - SWOT Analysis

    SWOT Analysis - Overview

    Active Biotech AB - Strengths

    Active Biotech AB - Weaknesses

    Active Biotech AB - Opportunities

    Active Biotech AB - Threats

    Active Biotech AB - Key Competitors

    Section 3 – Company Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Performance Chart

    Financial Performance

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 – Company’s Lifesciences Financial Deals and Alliances

    Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

    Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

    Active Biotech AB, Recent Deals Summary

    Section 5 – Company’s Recent Developments

    Feb 14, 2019: Active Biotech year-end report January - December 2018

    Nov 14, 2018: Active Biotech - Interim report January - September 2018

    Sep 13, 2018: TOPC : Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018" [Newswire : Healthcare - GNW RSS]

    Sep 07, 2018: Teva returns laquinimod global rights to Active Biotech

    Aug 09, 2018: Active Biotech - interim report January - June 2018

    May 18, 2018: Annual General Meeting of Active Biotech

    May 17, 2018: Active Biotech: Interim report January - March 2018

    Feb 15, 2018: Active Biotech: Year-end report January - December 2017

    Section 6 – Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

List Of Tables
in Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review

List of Tables

Active Biotech AB, Key Facts

Active Biotech AB, Key Employees

Active Biotech AB, Key Employee Biographies

Active Biotech AB, Major Products and Services

Active Biotech AB, History

Active Biotech AB, Subsidiaries

Active Biotech AB, Key Competitors

Active Biotech AB, Ratios based on current share price

Active Biotech AB, Annual Ratios

Active Biotech AB, Annual Ratios (Cont...1)

Active Biotech AB, Interim Ratios

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Active Biotech AB, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review

List of Figures

Active Biotech AB, Performance Chart (2014 - 2018)

Active Biotech AB, Ratio Charts

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Active Biotech AB, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Additional Details

Publisher

Global Data

Publisher Information

Reference

231982 |

Number of Pages

48

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Active Motif - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryActive Motif is a biotechnology company that develops and delivers biological research tools ...
29 Jul 2016 by Global Data USD $250 More Info
Active Biotech AB (ACTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryActive Biotech AB (Active Biotech) is a biotechnology company. It undertakes the development ...
28 Jul 2016 by Global Data USD $250 More Info
Active Implants LLC - Medical Equipment - Deals and Alliances Profile
SummaryActive Implants LLC (Active Implants), formerly Active Implants Corporation is a medical devi...
20 Jul 2016 by Global Data USD $250 More Info
Active Motif - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryActive Motif is a biotechnology company that develops and delivers biological research tools ...
05 May 2016 by Global Data USD $250 More Info
Active Implants LLC - Medical Equipment - Deals and Alliances Profile
SummaryActive Implants LLC (Active Implants) is a medical device company that manufactures orthopedi...
07 Apr 2016 by Global Data USD $250 More Info
Active Biotech AB (ACTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryActive Biotech AB (Active Biotech) is a biotechnology company. It undertakes the development ...
05 Apr 2016 by Global Data USD $250 More Info
Active Motif - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryActive Motif is a biotechnology company that develops and delivers biological research tools ...
08 Mar 2016 by Global Data USD $250 More Info
Active Biotech AB (ACTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryActive Biotech AB (Active Biotech) is a biotechnology company. It undertakes the development ...
03 Mar 2016 by Global Data USD $250 More Info
Active Implants LLC - Medical Equipment - Deals and Alliances Profile
SummaryActive Implants LLC (Active Implants) is a medical device company that manufactures orthopedi...
23 Feb 2016 by Global Data USD $250 More Info
Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review
Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth str...
08 Dec 2015 by Global Data USD $125 More Info

This report is published by Global Data

Download Free Report Summary PDF

Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...